Medstar Health, Inc.

Medstar Health, Inc., doing business as Medstar Health VNA, is a non-profit healthcare organization that provides a wide range of medical services and research support to federal agencies. As a corporate entity with tax-exempt status, Medstar Health has secured numerous federal contract and grant awards since its registration in 2016. The organization leverages its extensive healthcare network and expertise to deliver clinical care, conduct medical research, and support public health initiatives. While specific details about Medstar Health's background are limited, its involvement in diverse healthcare projects suggests it is a major provider in the Washington D.C. area with significant capabilities in both patient care and biomedical research.

Through federal contract awards, Medstar Health has demonstrated its capacity to provide specialized healthcare services and research support. Notably, the organization has been involved in COVID-19 related initiatives, such as participating in the ECHO National Nursing Home COVID-19 Action Network. In this capacity, Medstar Health Institute for Quality & Safety delivered comprehensive training and support to nursing homes, focusing on infection control, quality improvement, and pandemic response. The organization has also received contracts from the Department of Veterans Affairs for organ transplant services, showcasing its advanced medical capabilities. Additionally, Medstar has provided animal housing services for research purposes to the VA, highlighting its role in supporting biomedical studies. Many of these contract awards have been issued without set-aside designations, reflecting Medstar's status as an established healthcare provider capable of handling complex medical services and research support.

Medstar Health's involvement in federal grant programs further illustrates its diverse capabilities in healthcare and research. The organization has worked with the Maryland Department of Health to implement the Maryland Breast and Cervical Cancer Early Detection Program, providing crucial screening, diagnostic testing, and patient navigation services. In collaboration with the Maryland Hospital Association, Medstar developed training materials focused on healthcare worker safety during the COVID-19 pandemic, demonstrating its expertise in medical education and safety protocols. The organization has also received sub-awards through the Maryland Department of Emergency Management for COVID-19 emergency medical care and grant management, showcasing its role in emergency response and healthcare administration. Additionally, Medstar Health Research Institute (MHRI) has partnered with academic institutions like the University of New Mexico on research projects involving American Indian communities, focusing on topics such as cerebral vascular disease. These grant-funded activities highlight Medstar's commitment to public health, medical research, and addressing healthcare disparities in diverse populations.

Medstar Health holds several Indefinite Delivery Vehicles (IDVs) that allow federal agencies to efficiently procure its services. The National Heart, Lung, and Blood Institute (NHLBI) awarded Medstar an IDV for cardiovascular MRI consumables, enabling the institute to supply these materials as needed through 2027. This long-term agreement underscores Medstar's expertise in advanced medical imaging and its ability to support ongoing research initiatives. Another IDV provides for on-call cardiothoracic physician coverage to support NHLBI research programs, demonstrating Medstar's capacity to offer specialized medical expertise on demand. Furthermore, Medstar is part of the Agency for Healthcare Research and Quality's ACTION IV contract vehicle, which supports initiatives to accelerate healthcare quality improvement and organizational transformation. These IDVs position Medstar as a trusted, long-term partner for federal health research, clinical care, and quality improvement efforts across multiple agencies and healthcare domains.